ArticleJournal of vascular surgery cases and innovative techniques2025
Single-center experience in hybrid approach for subclavian vein effort thrombosis.
Article in Journal of vascular surgery cases and innovative techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Effort thrombosis of the subclavian vein (SCV) is one of the forms of deep vein thrombosis in the upper extremity and plays the leading role in venous thoracic outlet syndrome. This condition affects predominantly young and active people and can lead to extremity functional deterioration and long-term consequences. Despite the apparent clinical importance, no consensus or accepted protocol regarding optimal treatment exists. The main aim of this study was to present our local treatment protocol and to assess its effectiveness, safety, and functional impact. Methods: We conducted a single-center retrospective analysis of 27 patients hospitalized and treated in our department with effort SCV thrombosis from September 2005 to December 2022. The median length of follow-up was 92 months (range, 6-140 months). Evaluation of early and late stent patency and the assessment of chronic venous insufficiency, using the Villalta score and arm functional status using the QuickDASH-9 questionnaire, were performed. Results: Of these 27 patients, 23 were treated using catheter-directed thrombolysis, first rib resection with subsequent endovascular repair of the SCV using a self-expanding stent. A total of 18 patients were assessed for vein patency and showed an early patency of 94.4% and a late patency of 83.3%. Four stents were found to be occluded. None of the treated patients has developed clinically significant chronic venous insufficiency, and the median Villalta score was 1 point. The median functional status of the arm measured by the QuickDASH-9 questionnaire was 2.75. Conclusions: First rib resection is an integral part of the treatment approach and is prominent in releasing chronic bony compression of the SCV. Subsequent endovascular repair achieves unaffected prograde flow and excellent long-term vein patency. Despite surgical aggressiveness, the current approach shows promising results in the context of the safety and functional status of the affected limb.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.